Who are Azubromaron's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Norvir, Propecia, Diflucan, Profenol, Phenylbutazon, Sulfabid.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/benzbromarone.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Azubromaron — Competitive Intelligence Brief

Azubromaron (BENZBROMARONE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: benzbromarone. Area: Immunology.

marketed benzbromarone Cytochrome P450 2C9 Immunology Small molecule Live · refreshed every 30 min

Target snapshot

Azubromaron (BENZBROMARONE).

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Azubromaron TARGET	BENZBROMARONE		marketed	benzbromarone	Cytochrome P450 2C9
Norvir	ritonavir	AbbVie	marketed	Cytochrome P450 3A Inhibitor [EPC]	Cytochrome P450 2C9	1996-01-01
Propecia	finasteride	Merck & Co.	marketed	5-alpha-reductase inhibitor	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1, Cytochrome P450 2C19, Cytochrome P450 2C9	1992-06-19
Diflucan	fluconazole	Pfizer Inc.	marketed	Azole Antifungal [EPC]	Cytochrome P450 2C19, Cytochrome P450 2C9, Lanosterol 14-alpha demethylase	1990-01-29
Profenol	SUPROFEN	Novartis	marketed	suprofen	Cytochrome P450 2C9, Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2	1988-01-01
Phenylbutazon	PHENYLBUTAZONE	Novartis	marketed	phenylbutazone	Nicotinate phosphoribosyltransferase, Prostacyclin synthase, Cytochrome P450 2C9	1980-01-01
Sulfabid	SULFAPHENAZOLE	Purdue Frederick	marketed	sulfaphenazole	Cytochrome P450 2C9, Dihydropteroate synthase	1974-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (benzbromarone class)

· 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Azubromaron — Competitive Intelligence Brief. https://druglandscape.com/ci/benzbromarone. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab